Inglis Tiffany Eul Davis Insider Trades & Stock Holdings

Chief Medical Officer · Sera Prognostics, Inc. · Latest filing Oct 12, 2026

Inglis Tiffany Eul Davis, Chief Medical Officer at Sera Prognostics, Inc. has 2 Form 4 trades on file since Jun 11, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($17.02K), net -$17.02K. Latest filing: disposed of 8.02K shares of $SERA on Oct 12, 2026 at $2.03.

Trades on file

2

Open-market bought

$0

Open-market sold

$17.02K

Net open-market

-$17.02K

Latest filing

Oct 12, 2026

All insider trades by Inglis Tiffany Eul Davis

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 12, 2026	$SERA	Sell (Open-market sale)	8.02K	$2.03	$16.29K						Chief Medical Officer		Read
Jun 11, 2026	$SERA	Sell (Open-market sale)	362	$2.01	$727.62			-9.3%	-0.5%		Chief Medical Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Inglis Tiffany Eul Davis traded

• $SERA

Frequently asked questions

Has Inglis Tiffany Eul Davis been buying or selling stock?

Inglis Tiffany Eul Davis has 0 open-market purchases and 2 open-market sales on file, net -$17.02K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Inglis Tiffany Eul Davis's latest insider trade?

disposed of 8.02K shares of $SERA on Oct 12, 2026 at $2.03.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.